Wisconsin Public Meeting Notices & Minutes

Wisconsin has a rich tradition of open and transparent government. My administration is committed to making government more accessible to you, the citizens of Wisconsin. The goal of this website is to be a centralized location for state agencies to post open meeting notices and meeting minutes in an effort to increase state government transparency.

Public Notices

  1. Home
  2. Public Notices

Meeting Documents

Division of Medicaid Services Drug Utilization Review Board

12/06/2023 01:00 PM - 12 /06/2023 04:00 PM

To register for this meeting, please right click on the link below. You may need to copy and paste this link in your browser. https://dhswi.zoomgov.com/w/1608686163?tk=gQZSNOzl-ML-LnT6zTGCNUw9tVM_8596d6lNDJOdV_0.DQUAAAAAX-KaUxpmYWtlVEtybnM0cmdSS0NCcm5Sa2RaXzlOQQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA To register for this meeting by phone, please call: 1+ (646) 828-7666 (US Toll) or 1+ (669) 254-5252 Meeting ID: 160 868 6163, N/A, WI- 53703

Map

Agency: Department of Health Services
Contact: Emily Gentry
334-739-9555
Tiffany.Reilly@dhs.wisconsin.gov

Division of Medicaid Services
Wednesday, December 6, 2023
1:00PM to 4:00PM
Virtual Meeting
To register for this meeting, please right click on the link below. You may need to copy and paste this link in your browser.
https://dhswi.zoomgov.com/w/1608686163?tk=gQZSNOzl-ML-LnT6zTGCNUw9tVM_8596d6lNDJOdV_0.DQUAAAAAX-KaUxpmYWtlVEtybnM0cmdSS0NCcm5Sa2RaXzlOQQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
To register for this meeting by phone, please call:
1+ (646) 828-7666 (US Toll) or 1+ (669) 254-5252
Meeting ID: 160 868 6163
AGENDA
1:00-1:05 Welcome and Introductions Kim Wohler
1:05-1:10 Review of the Agenda and Board Materials Kim Wohler
1:10-1:15 Approval of Minutes: September 13, 2023 Kim Wohler
1:15-1:45 Updates Lynn Radmer, RPh
• Quarterly Reports
1:45-2:00 Sickle Cell Medication Underutilization Lynn Radmer, RPh
2:00-2:15 Buprenorphine & Benzodiazepine Intervention Katie Counts, PharmD
Lynn Radmer, RPh
2:15-2:30 Buprenorphine & Opioid Intervention Katie Counts, PharmD
2:30-2:45 Break
2:45-3:05 Lock-In Days’ Supply Katie Counts, Pharm D
3:05-3:25 Mood Stabilizers in Children Burt Copeland, MD
3:25-3:40 PDMP Discussion Lynn Radmer, RPh
3:40-3:50 PDL Update Lynn Radmer, RPh
3:50 Adjournment Kim Wohler
The purpose of this meeting is to conduct the governmental business outlined in the above agenda. The Drug Utilization Review Board is a federally mandated Board which meets on a quarterly basis to review and make recommendations to the Department on predetermined standards for retrospective and prospective drug utilization.
DHS is an equal opportunity employer and service provider. If you need accommodations because of a disability, if you need an interpreter or translator, or if you need this material in another language or in alternate format, you may request assistance to participate by contacting Emily Gentry at (334) 739-9555.


Americans with Disabilities Act Statement 

Reasonable accommodations, including the provision of informational material in an alternative format, will be provided for qualified individuals with disabilities upon request. This agency, to the maximum extent possible, holds all meetings in facilities that are physically accessible to persons with disabilities.  For questions about accessibility, contact the meeting's sponsoring division.


Back to Public Notices